Investor Key Data: Tech Tour Bio-based Industries 2025
Participating investors made a total of 3,500+ investments in the past, contributing to €170 Billion in total investments.
The upcoming flagship Tech Tour Bio-based Industries 2025 investment programme is once again set to gather the cream of the crop in the industry this November 13th in Wuppertal, Germany. With 40 handpicked companies, selected by 45+ seasoned investors, an exciting gathering of minds is shaping up. The selected companies are chosen from a large pool of applicants through a collaborative scouting and review process.
Key insights on participating investors:
Investor commitment: We are joined on the Selection Panel by 44 active investors who made a total of 3,577 investments in the past, contributing to more than €170,5 Billion in total investments.
Investor mix: The Selection Panel brings together leading venture funds and corporates shaping the future of bio-based industries. The Panel is compiled of 65% investment funds and 35% corporates.
Top investors: Among the most active participating investors, by number of past investments, are High-Tech Gründerfonds, Novo Nordisk, Mercia Asset Management, Rabobank, Mitsui & Co, Sofinnova Partners, Bayer, Demeter Partners, Bmp Ventures, Emerald Technology Ventures, eCAPITAL, Capricorn Partners and Hitachi.
For more insights see the Infogram below.
Investors and selected companies will gather onsite in Wuppertal this November 13th at Tech Tour Bio-based Industries 2025. The event is co-hosted by Bio-based Industries Consortium and Circular Valley.
Sign up for our newsletter and stay in the loop on all upcoming programme news.